115 related articles for article (PubMed ID: 17039675)
1. Diagnosis and management of hypersensitivity reactions caused by oxaliplatin.
Herrero T; Tornero P; Infante S; Fuentes V; Sánchez MN; De Barrio M; Baeza ML
J Investig Allergol Clin Immunol; 2006; 16(5):327-30. PubMed ID: 17039675
[TBL] [Abstract][Full Text] [Related]
2. Hypersensitivity Reaction and Rapid Drug Desensitization with Chemotherapeutics: A Tertiary Reference Center Experiences.
Bulut İ; Yegin Katran Z
Int Arch Allergy Immunol; 2023; 184(9):849-855. PubMed ID: 37442106
[TBL] [Abstract][Full Text] [Related]
3. Differential presentation of hypersensitivity reactions to carboplatin and oxaliplatin: Phenotypes, endotypes, and management with desensitization.
Jimenez-Rodriguez TW; de Las Vecillas L; Labella M; Lynch DM; Besz KM; Marquis K; Burgos A; Soriano Gomis V; Lozano I; Antón RAM; de la Calle FM; González Delgado MP; Gutiérrez A; Montenegro E; Rodríguez F; Fernández Sánchez FJ; Castells M
Allergy; 2024 Mar; 79(3):679-689. PubMed ID: 37916741
[TBL] [Abstract][Full Text] [Related]
4. Cytokine profiling, pretreatment with anakinra, and tolerance development in platinum-induced mixed hypersensitivity reactions.
Picard M; Filion CA; Auclair MH; Noujaim J; de Guerké L; Dionne JL; Beaudet J; Amireault C; Fortin S
Ann Allergy Asthma Immunol; 2023 Oct; 131(4):501-512.e9. PubMed ID: 37321446
[TBL] [Abstract][Full Text] [Related]
5. Hypersensitivity reaction to nedaplatin: A case report and literature review.
Gan K; Ma D
Medicine (Baltimore); 2023 Dec; 102(50):e36690. PubMed ID: 38115255
[TBL] [Abstract][Full Text] [Related]
6. Adverse reactions to targeted and non-targeted chemotherapeutic drugs with emphasis on hypersensitivity responses and the invasive metastatic switch.
Baldo BA; Pham NH
Cancer Metastasis Rev; 2013 Dec; 32(3-4):723-61. PubMed ID: 24043487
[TBL] [Abstract][Full Text] [Related]
7. Improving care using outpatient electronic consults in patients with chemotherapy hypersensitivity reactions.
Banerji A; Phadke N; McMahon AE; Cogan AS; Blumenthal KG
J Allergy Clin Immunol Pract; 2024 May; 12(5):1368-1371. PubMed ID: 37951415
[No Abstract] [Full Text] [Related]
8. Introduction to drug allergy, and whom to refer for specialist assessment?
Kasternow B; Karim MY
Clin Med (Lond); 2016 Dec; 16(6):588-592. PubMed ID: 27927827
[TBL] [Abstract][Full Text] [Related]
9. Rechallenge After Oxaliplatin-Induced Hypersensitivity Reactions.
Rassy E; Le Roy F; Smolenschi C; Valéry M; Boige V; Ducreux M; Boilève A
JAMA Oncol; 2023 Mar; 9(3):434-435. PubMed ID: 36701137
[TBL] [Abstract][Full Text] [Related]
10. Recognizing Drug Hypersensitivity in Pigmented Skin.
Lehloenya RJ; Phillips EJ; Pasieka HB; Peter J
Immunol Allergy Clin North Am; 2022 May; 42(2):219-238. PubMed ID: 35469616
[TBL] [Abstract][Full Text] [Related]
11. Management of suspected hypersensitivity reactions to anti-TB drugs.
Mutlu L; Bermingham WH; Mohamed OE; Melchior C; Samuel L; Heslegrave J; Baretto R; Ekbote A; Huissoon A; Dedicoat M; Krishna MT
Int J Tuberc Lung Dis; 2023 Jul; 27(7):570-573. PubMed ID: 37353875
[No Abstract] [Full Text] [Related]
12. Oxaliplatin desensitization for ovarian
Nicholson K; Jia L; Rowe M; Esselen K; Joseph N; Zera CA; Lax T; Shea M
Gynecol Oncol Rep; 2024 Apr; 52():101354. PubMed ID: 38435348
[TBL] [Abstract][Full Text] [Related]
13. Kounis syndrome during an oxaliplatin desensitization protocol.
Giangrande N; Carral Maseda A; Lopez Arias JA; Perez Casares L; Martin Lazaro J; Nuñez Orjales R; Gonzalez Guzman LA; Carballada Gonzalez F
J Investig Allergol Clin Immunol; 2023 Dec; ():0. PubMed ID: 38078516
[No Abstract] [Full Text] [Related]
14. Skin Prick Testing Predicts Peach Hypersensitivity Reactions.
Kim JH
Allergy Asthma Immunol Res; 2021 Nov; 13(6):830-832. PubMed ID: 34734502
[No Abstract] [Full Text] [Related]
15. Outcomes with one-bag desensitization protocol for biologic and chemotherapy agents in 451 procedures.
Roibás-Veiga I; Méndez-Brea P; Castro-Murga M; González-Rivas M; Iriarte-Sotés P; López-Abad R; Cadavid-Moreno S; González-Fernández T; López-Freire S; Armisén M; Rodríguez-Vázquez V; Vidal C
Eur Ann Allergy Clin Immunol; 2024 May; ():. PubMed ID: 38813917
[No Abstract] [Full Text] [Related]
16. Platin chemotherapy hypersensitivity reactions: Expanding the scope of practice and improving care.
Levin AS; Bhattacharya G; Blumenthal K; Camargo CA; Banerji A
J Allergy Clin Immunol Pract; 2019; 7(5):1691-1695.e2. PubMed ID: 30578851
[No Abstract] [Full Text] [Related]
17. A new non-dilution rapid desensitization protocol successfully applied to all-grade platinum hypersensitivity.
Chung SJ; Kang SY; Kang RY; Kim YC; Lee KH; Kim TY; Han SW; Kang HR
Cancer Chemother Pharmacol; 2018 Nov; 82(5):777-785. PubMed ID: 30105458
[TBL] [Abstract][Full Text] [Related]
18. Outcome of 490 Desensitizations to Chemotherapy Drugs with a Rapid One-Solution Protocol.
Pérez-Rodríguez E; Martínez-Tadeo JA; Pérez-Rodríguez N; Hernández-Santana G; Callero-Viera A; Rodríguez-Plata E; García-Robaina JC
J Allergy Clin Immunol Pract; 2018; 6(5):1621-1627.e6. PubMed ID: 29361511
[TBL] [Abstract][Full Text] [Related]
19. Platinum desensitization in patients with carboplatin hypersensitivity: A single-institution retrospective study.
Altwerger G; Gressel GM; English DP; Nelson WK; Carusillo N; Silasi DA; Azodi M; Santin A; Schwartz PE; Ratner ES
Gynecol Oncol; 2017 Jan; 144(1):77-82. PubMed ID: 27789084
[TBL] [Abstract][Full Text] [Related]
20. Risk-stratification protocol for carboplatin and oxaliplatin hypersensitivity: repeat skin testing to identify drug allergy.
Wang AL; Patil SU; Long AA; Banerji A
Ann Allergy Asthma Immunol; 2015 Nov; 115(5):422-8. PubMed ID: 26298407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
